Setting

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Published: 30 Sep 2022 | Report Code: 10248844 | Pages: 149

Asia Pacific single cell multiomics market will grow by 21.8% annually with a total addressable market cap of $ 16,032.0 million over 2022-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication. Highlighted with 36 tables and 76 figures, this 149-page report “Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country. Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Software Based on Omics Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single Cell Genomics (SCG) • Single Cell Transcriptomics (SCT) • Single Cell Proteomics (SCP) • Single Cell Metabolomics (SCM) By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Clinical Research o Oncology o Cell Therapy o Immunology o Neurology o Cell Biology o Other Types of Clinical Research • Translation Research • Synthetic Biology By Sample Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Human Samples o Cancer Tissues o Stem Cells o Immune Cells o Brain Cells o Other Human Samples • Animal Samples • Microbial Samples By Workflow, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single-Cell Isolation and Dispensing o Fluorescence-Activated Cell Sorting (FACS) o Microfluidics o Magnetic-Activated Cell Sorting (MACS) o Random Seeding o Manual Cell Picking o Laser Capture Microdissection o Other Technologies of Single-Cell Isolation and Dispensing • Single-Cell Analysis o Polymerase Chain Reaction o Next-Generation Sequencing o Mass Cytometry o Mass Spectrometry o Other Technologies of Single-Cell Analysis By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Research and Academic Laboratories • Biopharmaceutical and Biotech Companies • Contract Research Organizations (CROs) • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 10x Genomics, Inc. 1CellBio, Inc. Becton, Dickinson and Company Berkeley Lights, Inc. BGI Genomics Co., Ltd. Bio-Rad Laboratories, Inc. Bio-Techne Corporation BioTuring, Inc. Danaher Corporation (Cytiva Life Sciences) Dolomite Bio Fluidigm Corporation Fluxion Biosciences Illimina, Inc Mission Bio, Inc. Namocell, Inc. NanoString Technologies, Inc. Parse Biosciences, Inc. Proteona Qiagen N.V. RareCyte, Inc. Scipio Biosciences SAS Shilps Sciences Takara Bio Inc. (Takara Holdings) Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	25
2.2 Major Growth Drivers	27
2.3 Market Restraints and Challenges	35
2.4 Emerging Opportunities and Market Trends	38
2.5 Porter’s Fiver Forces Analysis	42
3 Segmentation of Asia Pacific Market by Product Type	46
3.1 Market Overview by Product Type	46
3.2 Instruments	48
3.3 Consumables	49
3.4 Software	50
4 Segmentation of Asia Pacific Market by Omics Type	51
4.1 Market Overview by Omics Type	51
4.2 Single Cell Genomics (SCG)	53
4.3 Single Cell Transcriptomics (SCT)	54
4.4 Single Cell Proteomics (SCP)	55
4.5 Single Cell Metabolomics (SCM)	56
5 Segmentation of Asia Pacific Market by Application	57
5.1 Market Overview by Application	57
5.2 Clinical Research	59
5.2.1 Oncology	61
5.2.2 Cell Therapy	62
5.2.3 Immunology	63
5.2.4 Neurology	64
5.2.5 Cell Biology	65
5.2.6 Other Types of Clinical Research	66
5.3 Translation Research	67
5.4 Synthetic Biology	68
6 Segmentation of Asia Pacific Market by Sample Type	69
6.1 Market Overview by Sample Type	69
6.2 Human Samples	71
6.2.1 Cancer Tissues	73
6.2.2 Stem Cells	74
6.2.3 Immune Cells	75
6.2.4 Brain Cells	76
6.2.5 Other Human Samples	77
6.3 Animal Samples	78
6.4 Microbial Samples	79
7 Segmentation of Asia Pacific Market by Workflow	80
7.1 Market Overview by Workflow	80
7.2 Single-Cell Isolation and Dispensing	82
7.2.1 Fluorescence-Activated Cell Sorting (FACS)	84
7.2.2 Microfluidics	85
7.2.3 Magnetic-Activated Cell Sorting (MACS)	86
7.2.4 Random Seeding	87
7.2.5 Manual Cell Picking	88
7.2.6 Laser Capture Microdissection	89
7.2.7 Other Technologies of Single-Cell Isolation and Dispensing	90
7.3 Single-Cell Analysis	91
7.3.1 Polymerase Chain Reaction	93
7.3.2 Next-Generation Sequencing	94
7.3.3 Mass Cytometry	95
7.3.4 Mass Spectrometry	96
7.3.5 Other Technologies of Single-Cell Analysis	97
8 Segmentation of Asia Pacific Market by End User	98
8.1 Market Overview by End User	98
8.2 Research and Academic Laboratories	100
8.3 Biopharmaceutical and Biotech Companies	101
8.4 Contract Research Organizations (CROs)	102
8.5 Other End Users	103
9 Asia-Pacific Market 2021-2031 by Country	104
9.1 Overview of Asia-Pacific Market	104
9.2 Japan	107
9.3 China	110
9.4 Australia	112
9.5 India	114
9.6 South Korea	116
9.7 Rest of APAC Region	118
10 Competitive Landscape	120
10.1 Overview of Key Vendors	120
10.2 New Product Launch, Partnership, Investment, and M&A	123
10.3 Company Profiles	124
10x Genomics, Inc.	124
1CellBio, Inc.	126
Becton, Dickinson and Company	127
Berkeley Lights, Inc.	128
BGI Genomics Co., Ltd.	129
Bio-Rad Laboratories, Inc.	130
Bio-Techne Corporation	131
BioTuring, Inc.	132
Danaher Corporation (Cytiva Life Sciences)	133
Dolomite Bio	134
Fluidigm Corporation	135
Fluxion Biosciences	136
Illimina, Inc	137
Mission Bio, Inc.	138
Namocell, Inc.	139
NanoString Technologies, Inc.	140
Parse Biosciences, Inc.	141
Proteona	142
Qiagen N.V.	143
RareCyte, Inc.	144
Scipio Biosciences SAS	145
Shilps Sciences	146
Takara Bio Inc. (Takara Holdings)	147
Thermo Fisher Scientific Inc.	148
RELATED REPORTS	149
List of Tables:


Table 1.  Snapshot of Asia Pacific Single Cell Multiomics Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Economic Outlook, 2021-2023	23
Table 4. Comparison of Rare Disease in Different Countries	32
Table 5. World Health Spending by Region, $ bn, 2013-2020	34
Table 6.  Main Product Trends and Market Opportunities in Asia Pacific Single Cell Multiomics Market	38
Table 7. Asia Pacific Single Cell Multiomics Market by Product Type, 2021-2031, $ mn	46
Table 8. Asia Pacific Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	51
Table 9. Asia Pacific Single Cell Multiomics Market by Application, 2021-2031, $ mn	57
Table 10. Asia Pacific Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn	60
Table 11. Asia Pacific Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn	69
Table 12. Asia Pacific Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn	72
Table 13. Asia Pacific Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	80
Table 14. Asia Pacific Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn	83
Table 15. Asia Pacific Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn	92
Table 16. Asia Pacific Single Cell Multiomics Market by End User, 2021-2031, $ mn	98
Table 17. APAC Single Cell Multiomics Market by Country, 2021-2031, $ mn	105
Table 18. Japan Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	109
Table 19. Japan Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	109
Table 20. Japan Single Cell Multiomics Market by End User, 2021-2031, $ mn	109
Table 21. China Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	111
Table 22. China Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	111
Table 23. China Single Cell Multiomics Market by End User, 2021-2031, $ mn	111
Table 24. Australia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	113
Table 25. Australia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	113
Table 26. Australia Single Cell Multiomics Market by End User, 2021-2031, $ mn	113
Table 27. India Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	115
Table 28. India Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	115
Table 29. India Single Cell Multiomics Market by End User, 2021-2031, $ mn	115
Table 30. South Korea Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn	117
Table 31. South Korea Single Cell Multiomics Market by Workflow, 2021-2031, $ mn	117
Table 32. South Korea Single Cell Multiomics Market by End User, 2021-2031, $ mn	117
Table 33. Single Cell Multiomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn	119
Table 34. 10x Genomics, Inc.: Company Snapshot	124
Table 35. 10x Genomics, Inc.: Business Segmentation	125
Table 36. 10x Genomics, Inc.: Product Portfolio	125
List of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Asia Pacific Single Cell Multiomics Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	25
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Single Cell Multiomics Market	27
Figure 7.  Leading Causes of Death in the World, 2000 and 2019, million	30
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019	31
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	33
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Single Cell Multiomics Market	35
Figure 12. Investment Opportunity Analysis	39
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Single Cell Multiomics Market	42
Figure 14. Breakdown of Asia Pacific Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue	47
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)	47
Figure 16. Asia Pacific Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn	48
Figure 17. Asia Pacific Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn	49
Figure 18. Asia Pacific Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn	50
Figure 19. Breakdown of Asia Pacific Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue	52
Figure 20. Asia Pacific Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%)	52
Figure 21. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn	53
Figure 22. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn	54
Figure 23. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn	55
Figure 24. Asia Pacific Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn	56
Figure 25. Breakdown of Asia Pacific Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue	58
Figure 26. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	58
Figure 27. Asia Pacific Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn	59
Figure 28. Asia Pacific Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn	61
Figure 29. Asia Pacific Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn	62
Figure 30. Asia Pacific Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn	63
Figure 31. Asia Pacific Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn	64
Figure 32. Asia Pacific Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn	65
Figure 33. Asia Pacific Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn	66
Figure 34. Asia Pacific Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn	67
Figure 35. Asia Pacific Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn	68
Figure 36. Breakdown of Asia Pacific Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue	70
Figure 37. Asia Pacific Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)	70
Figure 38. Asia Pacific Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn	71
Figure 39. Asia Pacific Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn	73
Figure 40. Asia Pacific Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn	74
Figure 41. Asia Pacific Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn	75
Figure 42. Asia Pacific Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn	76
Figure 43. Asia Pacific Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn	77
Figure 44. Asia Pacific Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn	78
Figure 45. Asia Pacific Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn	79
Figure 46. Breakdown of Asia Pacific Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue	81
Figure 47. Asia Pacific Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%)	81
Figure 48. Asia Pacific Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn	82
Figure 49. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn	84
Figure 50. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn	85
Figure 51. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn	86
Figure 52. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn	87
Figure 53. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn	88
Figure 54. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn	89
Figure 55. Asia Pacific Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn	90
Figure 56. Asia Pacific Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn	91
Figure 57. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn	93
Figure 58. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn	94
Figure 59. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn	95
Figure 60. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn	96
Figure 61. Asia Pacific Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn	97
Figure 62. Breakdown of Asia Pacific Single Cell Multiomics Market by End User, 2021-2031, % of Revenue	98
Figure 63. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	99
Figure 64. Asia Pacific Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn	100
Figure 65. Asia Pacific Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn	101
Figure 66. Asia Pacific Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn	102
Figure 67. Asia Pacific Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn	103
Figure 68. Breakdown of APAC Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue	105
Figure 69. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	106
Figure 70.  Single Cell Multiomics Market in Japan, 2021-2031, $ mn	108
Figure 71.  Single Cell Multiomics Market in China, 2021-2031, $ mn	110
Figure 72.  Single Cell Multiomics Market in Australia, 2021-2031, $ mn	112
Figure 73.  Single Cell Multiomics Market in India, 2021-2031, $ mn	114
Figure 74.  Single Cell Multiomics Market in South Korea, 2021-2031, $ mn	116
Figure 75.  Single Cell Multiomics Market in Rest of APAC, 2021-2031, $ mn	118
Figure 76. Growth Stage of Asia Pacific Single Cell Multiomics Industry over the Forecast Period	120

Selected Key Players: 
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)